AIM: The radiation exposure in radiation synovectomy was investigated for technician and therapist using Erbium-169, Rhenium-186 and Yttrium-90 with and without syringe shieldings. METHODS: Dose rates were measured in relation to the distance of the syringe containing the radionuclide...
Keywords: Spritzenabschirmung, Radiosynoviorthese, Strahlen-exposition, Betastrahler, Erbium-169, Rhenium-186, Yttrium-90
01/2003 | Nuklearmedizin, SchattauerThis guideline is a prerequisite for the quality management in the treatment of non-Hodgkin-lymphomas using radioimmunotherapy...
Keywords: Radioimmuntherapie, Non-Hodgkin-Lymphom, CD20-Rezeptoren, Zevalin, Yttrium-90
01/2004 | Nuklearmedizin, Schattauer90Y-ibritumomab tiuxetan (Zevalin) is currently approved for radioimmunotherapy of patients with relapsed or refractory follicular non-Hodgkins lymphoma pretreated with rituximab...
Keywords: Ibritumomab-Tiuxetan, Zevalin®, Yttrium-90, Radioimmuntherapie, Aktivimeter, Strahlenschutz
01/2005 | Nuklearmedizin, SchattauerAim: Multiple procedures for the quantification of activity leakage in radiation synovectomy of the knee joint have been described in the literature...
Keywords: Bremsstrahlung, Yttrium-90, Radiosynoviorthese, Phantommessung, Aktivitäsabtransport
01/2006 | Nuklearmedizin, SchattauerRadiosynoviorthesis (RSO) with the -particle-emitting nuclide yttrium-90 is an established concept for the treatment of persistent synovitis of the knee joint...
Keywords: Yttrium-90, Radiosynoviorthese, Strahlenschutz, Chromosomenaberration, biologische Dosimetrie
01/2006 | Nuklearmedizin, Schattauer